Abstract
Ten flavonoid compounds isolated from the methanolic extract of a tropical weed plant,Chromolaena odorata leaves were tested against three multidrug-resistant (MDR) methicillin-resistant Staphylococcus aureus (MRSA) isolates with active efflux properties. Only low inhibitory potential were detected through the preliminary evaluation as indicated by their respective minimum inhibitory concentration (MIC) value. These results justify the need to conduct subsequent evaluation namely the efflux inhibitory potential assay. Ethidium bromide (EtBr) and reserpine were used as the standard efflux substrate and efflux inhibitor, respectively while S. aureus ATCC 25923 was used as the reference strain. Three flavonoid compounds namely eriodictyol-7,4’-dimethyl ether, naringenin-4’-methyl ether and 2’4-dihydroxy-4’5’6’-trimethoxychalcone showed high efflux inhibitory activity with four to eight fold reduction of EtBr MIC value, hence suggesting their potential to be develop into efflux inhibitors for MRSA. Key words: Chromolaena odorata, methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant (MDR), efflux pump inhibitor, minimum inhibitory concentration (MIC) assay.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
